Form 4: Omeros Corp Director Peter Demopulos Receives Stock Option Award

Director Peter Demopulos received a stock option to purchase 15,000 shares of Omeros Corp common stock on June 6, 2024, as part of the company's non-employee director compensation policy.

Summary

• Peter Demopulos, a director at Omeros Corp, was granted a stock option to purchase 15,000 shares of common stock on June 6, 2024.
• The grant is part of Omeros Corporation's non-employee director compensation policy.
• The option was awarded in conjunction with the annual meeting of shareholders held on June 6, 2024.
• The option will fully vest and become exercisable on the day before the date of the 2025 annual meeting of shareholders, contingent upon continued service as a director.

Sentiment

Score: 7

Explanation: The document reflects a routine compensation practice, indicating stability and alignment of interests. It's a neutral-positive signal.

Positives

• The stock option grant aligns director compensation with shareholder interests.
• The vesting schedule incentivizes continued service as a director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Stock option grants are a common form of compensation for non-employee directors, aligning their interests with those of shareholders by incentivizing them to increase the company's stock value.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary widely across the biotechnology industry depending on company size, stage of development, and performance.
• Companies like Amgen, Gilead, and Regeneron typically offer more substantial equity grants to their directors due to their larger market capitalization and revenue generation.
• Smaller biotech firms, such as Omeros, often use stock options to conserve cash while still attracting and retaining qualified board members.

Stakeholder Impact

• Shareholders: The stock option grant aligns director interests with shareholder value.
• Directors: The grant provides additional compensation and incentivizes continued service.

Key Dates